Elevated CRP levels significantly increased the risk of postmenopausal breast cancer (OR = 1.08, 95% CI: 1.00-1.16), but not significantly for premenopausal breast cancer (OR = 1.08, 95% CI: 0.91-1.28). Here, CRP is linked to breast carcinoma.